Brooks Laboratories (BROOKS.NS) Stock Price

Brooks Laboratories Price

CLOSED
60.01INR-0.04 (-0.07 %)
Market closed

Revenue has compounded at 7.3% per year over the past 18 years to 825.57 M INR. Earnings per share have declined at 1.2% per year over the last 10 years. Brooks Laboratories's net margin stands at -12.1%, up from -25.1% several years earlier. The stock trades about 62% above its 52-week low.

Brooks Laboratories stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Brooks Laboratories over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Brooks Laboratories stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Brooks Laboratories's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Brooks Laboratories Stock Price History
DateBrooks Laboratories Price
8/7/202660.01 INR
8/6/202660.05 INR
8/5/202660.29 INR
8/3/202662.40 INR
7/30/202660.99 INR
7/28/202664.50 INR
7/24/202664.06 INR
7/23/202665.98 INR
7/22/202667.75 INR
7/20/202667.75 INR
7/17/202669.46 INR
7/16/202669.79 INR
7/15/202669.12 INR
7/14/202669.29 INR
7/13/202669.85 INR
7/10/202670.44 INR
7/9/202670.51 INR
7/8/202669.61 INR
7/7/202676.75 INR
7/6/202676.87 INR
7/3/202677.21 INR
7/2/202675.91 INR
7/1/202672.30 INR
6/30/202668.86 INR
6/29/202669.93 INR
6/25/202673.55 INR
6/24/202676.80 INR
6/23/202673.51 INR
6/22/202670.01 INR
6/19/202666.68 INR
6/18/202668.00 INR
6/17/202666.97 INR
6/16/202667.12 INR
6/15/202667.55 INR
6/12/202666.56 INR
6/11/202665.05 INR
6/10/202667.74 INR
6/9/202668.23 INR
6/8/202666.66 INR
6/5/202665.68 INR
6/4/202664.88 INR
6/3/202664.40 INR
6/2/202667.05 INR
6/1/202668.55 INR
5/29/202665.29 INR
5/28/202662.19 INR
5/27/202662.19 INR
5/26/202659.23 INR
5/25/202656.41 INR
5/22/202653.73 INR
5/21/202651.18 INR
5/20/202649.51 INR
5/19/202648.42 INR
5/18/202646.12 INR
5/15/202646.61 INR
5/14/202648.00 INR
5/13/202647.68 INR
5/12/202649.81 INR
5/11/202647.46 INR
5/8/202649.93 INR
5/7/202652.55 INR
5/6/202655.29 INR
5/5/202654.26 INR
5/4/202654.54 INR
5/1/202655.98 INR
4/30/202655.98 INR
4/29/202658.86 INR
4/28/202661.78 INR
4/27/202664.46 INR
4/24/202667.54 INR
4/23/202664.36 INR
4/22/202661.30 INR
4/21/202664.04 INR
4/20/202665.66 INR
4/17/202667.58 INR
4/16/202669.58 INR
4/15/202672.07 INR
4/13/202671.62 INR
4/10/202672.20 INR
4/9/202671.57 INR
4/8/202671.73 INR
4/7/202673.23 INR
4/6/202664.05 INR
4/2/202653.38 INR
4/1/202644.53 INR
3/30/202637.11 INR
3/27/202643.21 INR
3/25/202646.78 INR
3/24/202647.03 INR
3/23/202646.03 INR
3/20/202652.64 INR
3/19/202654.26 INR
3/18/202656.96 INR
3/17/202655.40 INR
3/16/202657.03 INR
3/13/202658.17 INR
3/12/202662.18 INR
3/11/202660.91 INR
3/10/202662.47 INR
3/9/202658.46 INR
3/6/202661.00 INR
3/5/202661.73 INR
3/4/202661.80 INR
3/2/202662.63 INR
2/27/202667.11 INR
2/26/202668.00 INR
2/25/202668.14 INR
2/24/202670.97 INR
2/23/202672.97 INR
2/20/202674.47 INR
2/19/202675.55 INR
2/18/202676.65 INR
2/17/202673.60 INR
2/16/202674.35 INR
2/13/202675.81 INR
2/12/202677.35 INR
2/11/202678.14 INR
2/10/202674.18 INR
2/9/202669.23 INR
2/6/202660.93 INR
2/5/202660.96 INR
2/4/202661.28 INR
2/3/202659.87 INR
2/2/202660.19 INR
1/30/202661.55 INR
1/29/202661.90 INR
1/28/202664.40 INR
1/27/202663.18 INR
1/23/202665.52 INR
1/22/202667.06 INR
1/21/202665.13 INR
1/20/202665.00 INR
1/19/202668.11 INR
1/16/202668.35 INR
1/14/202669.23 INR
1/13/202671.47 INR
1/12/202671.58 INR
1/9/202674.21 INR
1/8/202674.71 INR
1/7/202675.84 INR
1/6/202676.31 INR
1/5/202676.89 INR
1/2/202677.26 INR
1/1/202677.63 INR
12/31/202580.14 INR
12/30/202570.49 INR
12/29/202577.77 INR
12/26/202586.31 INR
12/24/202590.00 INR
12/23/202592.69 INR
12/22/202593.83 INR
12/19/202593.89 INR
12/18/202595.82 INR
12/17/202596.64 INR
12/16/202597.13 INR
12/15/202595.99 INR
12/12/202598.04 INR
12/11/202597.93 INR
12/10/202595.37 INR
12/9/202596.71 INR
12/8/202595.24 INR
12/5/202597.82 INR
12/4/202598.50 INR
12/3/202598.88 INR
12/2/202599.60 INR
12/1/2025102.03 INR
11/28/2025102.20 INR
11/27/2025104.63 INR
11/26/2025105.13 INR
11/25/202599.93 INR
11/24/202596.28 INR
11/21/2025102.34 INR
11/20/2025105.15 INR
11/19/2025103.39 INR
11/18/2025104.56 INR
11/17/2025102.74 INR
11/14/2025106.95 INR
11/13/2025109.82 INR
11/12/2025102.35 INR
11/11/2025104.57 INR
11/10/2025103.19 INR
11/7/2025106.11 INR
11/6/2025105.21 INR
11/4/2025109.67 INR
11/3/2025111.94 INR
10/31/2025110.93 INR
10/30/2025111.62 INR
10/29/2025105.99 INR
10/28/2025106.78 INR
10/27/2025112.10 INR
10/24/2025113.30 INR
10/23/2025121.61 INR
10/21/2025120.95 INR
10/20/2025120.41 INR
10/17/2025122.43 INR
10/16/2025122.70 INR
10/15/2025123.18 INR
10/14/2025126.34 INR
10/13/2025128.11 INR
10/10/2025124.81 INR
10/9/2025130.95 INR
10/8/2025128.40 INR
10/7/2025127.88 INR
10/6/2025130.80 INR
10/3/2025135.34 INR
10/1/2025131.76 INR
9/30/2025134.25 INR
9/29/2025135.16 INR
9/26/2025135.50 INR
9/25/2025141.59 INR
9/24/2025145.42 INR
9/23/2025145.92 INR
9/22/2025147.08 INR
9/19/2025149.37 INR
9/18/2025149.92 INR
9/17/2025154.72 INR
9/16/2025156.53 INR
9/15/2025157.45 INR
9/12/2025159.04 INR
9/11/2025152.57 INR
9/10/2025151.33 INR
9/9/2025145.81 INR
9/8/2025147.72 INR
9/5/2025151.05 INR
9/4/2025145.53 INR
9/3/2025138.60 INR
9/2/2025135.22 INR
9/1/2025138.60 INR
8/29/2025134.70 INR
8/28/2025139.75 INR
8/26/2025139.39 INR
8/25/2025140.31 INR
8/22/2025144.34 INR
8/21/2025146.16 INR
8/20/2025152.01 INR
8/19/2025152.19 INR
8/18/2025150.12 INR
8/14/2025150.73 INR
8/13/2025156.21 INR
8/12/2025148.78 INR
Access this data via the Eulerpool API
Get Free API Key

Brooks Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
569.00 M INR
-153.30 M INR
-138.10 M INR
Jan 1, 2019
550.30 M INR
-148.60 M INR
-148.10 M INR
Jan 1, 2020
696.90 M INR
-92.20 M INR
-243.80 M INR
Jan 1, 2021
772.50 M INR
-65.70 M INR
-193.80 M INR
Jan 1, 2022
910.80 M INR
-217.10 M INR
-161.90 M INR
Jan 1, 2023
632.05 M INR
-334.02 M INR
-209.00 M INR
Jan 1, 2024
794.86 M INR
14.44 M INR
-195.92 M INR
Jan 1, 2025
825.57 M INR
33.37 M INR
-99.67 M INR

Brooks Laboratories Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 11, 2026, 2:41 PM
 
REVENUEM INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM INR
EBITM INR
EBIT MARGIN%
NET INCOMEM INR
NET INCOME GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
451.00525.00560.00801.00852.00852.00800.00648.00569.00550.00696.00772.00910.00632.00794.00825.00
0.4516.416.6743.046.37–-6.10-19.00-12.19-3.3426.5510.9217.88-30.5525.633.90
21.9525.3331.2525.4731.3428.7633.7532.1028.6528.1832.7638.3422.429.6525.6930.79
99.00133.00175.00204.00267.00245.00270.00208.00163.00155.00228.00296.00204.0061.00204.00254.00
68.0086.0098.0096.0076.0057.0099.0033.00-153.00-148.00-92.00-65.00-217.00-334.0014.0033.00
15.0816.3817.5011.998.926.6912.385.09-26.89-26.91-13.22-8.42-23.85-52.851.764.00
51.0068.0088.0071.0072.0094.00106.0016.00-138.00-148.00-243.00-193.00-161.00-209.00-195.00-99.00
75.8633.3329.41-19.321.4130.5612.77-84.91-962.507.2564.19-20.58-16.5829.81-6.70-49.23
11.7011.8019.4019.4019.4019.4019.4019.4019.4019.4021.1024.7024.7024.9425.6226.79
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Brooks Laboratories generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Brooks Laboratories retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Brooks Laboratories's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Brooks Laboratories has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Brooks Laboratories's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Brooks Laboratories stock margins

The Brooks Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Brooks Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Brooks Laboratories.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
28.72 %
-26.94 %
-24.27 %
Jan 1, 2019
28.33 %
-27.00 %
-26.91 %
Jan 1, 2020
32.80 %
-13.23 %
-34.98 %
Jan 1, 2021
38.41 %
-8.50 %
-25.09 %
Jan 1, 2022
22.46 %
-23.84 %
-17.78 %
Jan 1, 2023
9.81 %
-52.85 %
-33.07 %
Jan 1, 2024
25.68 %
1.82 %
-24.65 %
Jan 1, 2025
30.83 %
4.04 %
-12.07 %

Brooks Laboratories Stock Revenue, EBIT, Earnings per Share

The Brooks Laboratories earnings per share therefore indicates how much revenue Brooks Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
29.33 INR
-7.90 INR
-7.12 INR
Jan 1, 2019
28.37 INR
-7.66 INR
-7.63 INR
Jan 1, 2020
33.03 INR
-4.37 INR
-11.55 INR
Jan 1, 2021
31.28 INR
-2.66 INR
-7.85 INR
Jan 1, 2022
36.87 INR
-8.79 INR
-6.55 INR
Jan 1, 2023
25.34 INR
-13.39 INR
-8.38 INR
Jan 1, 2024
31.03 INR
0.56 INR
-7.65 INR
Jan 1, 2025
30.81 INR
1.25 INR
-3.72 INR

Brooks Laboratories business model & stock analysis

Brooks Laboratories Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Brooks Laboratories historical P/E ratio, EBIT multiple, and P/S ratio

Brooks Laboratories annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Brooks Laboratories shares outstanding

The number of shares of Brooks Laboratories was 26.79 M in 2025. This indicates how many shares Brooks Laboratories is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
19.40 M Stocks
Jan 1, 2019
19.40 M Stocks
Jan 1, 2020
21.10 M Stocks
Jan 1, 2021
24.70 M Stocks
Jan 1, 2022
24.70 M Stocks
Jan 1, 2023
24.94 M Stocks
Jan 1, 2024
25.62 M Stocks
Jan 1, 2025
26.79 M Stocks
Price targets and forecasts for Brooks Laboratories are not yet available.

Brooks Laboratories shareholder structure

% Name
19.23985%
Ranchal (Atul)
Ranchal (Atul)
17.35964%
Mahajan (Rajesh)
Mahajan (Rajesh)
9.89854%
Quant Money Managers Ltd
Quant Money Managers Ltd
4.09535%
Mahajan (Erwin)
Mahajan (Erwin)
2.92383%
Ranchal (Rajni)
Ranchal (Rajni)
2.67227%
Ranchal (Savvy)
Ranchal (Savvy)

Brooks Laboratories Beneficial Ownership Filings (SEC 13D/G)

Free Float
44.9%
Float Shares
-
Shares Outstanding
-

Brooks Laboratories Executives and Management Board

9 members · avg. age 53 · 22 % women

RM

Mr. Rajesh Mahajan (56)

President - Procurement · since 2002

9.62 M INR

Management

PR

Mr. Prashant Rathi (35)

Chief Financial Officer

–
KR

Ms. Krutika Rane (32)

Compliance Officer, Company Secretary

–

Board of Directors

BR

Mr. Bhushan Rana (70)

Whole-Time Director · since 2023

2.33 M INR
DM

Dr. Durga Maity (62)

Whole-Time Director · since 2010

1.92 M INR
JS

Mr. Jitendra Singh (52)

Whole-Time Director · since 2022

870,000.00 INR
US

Ms. Usha Singh (57)

Non-Executive Independent Director

45,000.00 INR
LM

Mr. Lalit Mahajan (60)

Non-Executive Independent Director

30,000.00 INR
MM

Mr. Manav Mahajan (49)

Non-Executive Independent Director

15,000.00 INR

Frequently asked questions about Brooks Laboratories

Converted at the current exchange rate, the Brooks Laboratories share trades at 0.55 EUR (60.01 INR).

No history available for Brooks Laboratories.

The revenue cannot currently be calculated for Brooks Laboratories.

The profit cannot currently be calculated for Brooks Laboratories.

The P/E ratio cannot be calculated for Brooks Laboratories at the moment.

The P/S cannot be calculated for Brooks Laboratories currently.

The Eulerpool Quality Score for Brooks Laboratories is 2/10.

The ISIN of Brooks Laboratories is INE650L01011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Brooks Laboratories is BROOKS.NS. The ticker symbol is used to trade Brooks Laboratories shares on the stock exchange.

Brooks Laboratories paid dividends every year for the past 0 years.

Brooks Laboratories is assigned to the 'Health' sector.

The dividends of Brooks Laboratories are distributed in INR.

All fundamentals and in-depth analysis of Brooks Laboratories

Our stock analysis for Brooks Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Brooks Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Brooks Laboratories Stock
Brooks Laboratories Revenue→
Brooks Laboratories Stock
Brooks Laboratories Net Income→
Brooks Laboratories Stock
Brooks Laboratories P/E→
Brooks Laboratories Stock
Brooks Laboratories P/S→
Brooks Laboratories Stock
Brooks Laboratories EBIT→
Brooks Laboratories Stock
Brooks Laboratories Dividend→
Brooks Laboratories Stock
Brooks Laboratories Directors Dealings→
Brooks Laboratories Stock
Brooks Laboratories Stocks→
Brooks Laboratories Stock
Brooks Laboratories Market capitalization→
Brooks Laboratories Stock
Brooks Laboratories Debt→
Brooks Laboratories Stock
Brooks Laboratories Liabilities→
Brooks Laboratories Stock
Brooks Laboratories Equity→
Brooks Laboratories Stock
Brooks Laboratories AAQS→
Brooks Laboratories Stock
Brooks Laboratories Employees→
Brooks Laboratories Stock
Brooks Laboratories ROE→
Brooks Laboratories Stock
Brooks Laboratories ROA→
Brooks Laboratories Stock
Brooks Laboratories ROCE→
Brooks Laboratories Stock
Brooks Laboratories News→
Brooks Laboratories Stock
Brooks Laboratories Analyst Price Targets→

Health Stocks

BrukerBrookdale Senior LivingBrynBristol-Myers SquibbBSF EnterpriseBRIM BiotechnologyBTB Korea CoBrii BiosciencesBukwang Pharm CoBrightspring Health ServicesBullfrog AI HoldingsBrightPath Biotherapeutics CoAll Stocks A–Z →